ASCO 2023—partnering with patients: the cornerstone of cancer care and research Gabriel Rinnerthaler editorial 04 December 2023 Pages: 215 - 216
ASCO 2023: new treatment options in CNS tumors Josef Pichler short review 17 August 2023 Pages: 222 - 224
Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer Patrick ReimannThomas Winder short review 13 November 2023 Pages: 225 - 229
ASCO update—hepatocellular carcinoma and cholangiocellular carcinoma Angela Djanani short review Open access 27 October 2023 Pages: 234 - 236
Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma Aysegül Ilhan-MutluEwald Wöll short review Open access 19 October 2023 Pages: 237 - 241
Fifth-line HER2-directed therapy for metastatic adenocarcinoma of the gastroesophageal junction Sophie Roider-SchurSybille MachatLeopold Öhler case report 27 October 2023 Pages: 242 - 245
Comment to Smith MR, Hussain M, Saad F et al. (2022, N Engl J Med) Darolutamide and survival in metastatic, hormone-sensitive prostate cancer Isabel HeideggerAndreas Pircher comment 04 July 2022 Pages: 246 - 246
Focal therapy in intermediate- and high-risk prostate cancer Nicolai A. HuebnerStephan KornShahrokh F. Shariat short review Open access 10 November 2023 Pages: 247 - 250
Imaging and therapy targeting PSMA receptors for enhanced vision and precise treatment Sazan RasulStephan Korn short review Open access 19 October 2023 Pages: 251 - 254
Challenges in prevention, early detection, and management of febrile neutropenia in adult patients with solid tumors Petar Popov short review Open access 29 August 2023 Pages: 255 - 258
Erythropoiesis-stimulating agents—benefits and harms in the treatment of anemia in cancer patients Ronald HereggerRichard Greil short review Open access 28 August 2023 Pages: 259 - 262
Management of malignant hypercalcemia in cancer patients—a short review Clemens PetraschPetra MaricsThomas Spanberger short review 03 November 2023 Pages: 263 - 267
WNT3 and LEF1 as markers for diagnosis and survival prediction in chronic lymphocytic leukemia patients Manal AtefLayla M. SalehSameh Shamaa original report 13 October 2020 Pages: 268 - 274